To Compare Postoperative Horizontal Position Stability of the CT LUCIA 611P and the CT ASPHINA 409MP

Inclusion criteria

• Patient informed of the consequences and constraints of the protocol and who has given his/her written informed consent;
• Patients of any gender, aged 50 to 90 years;
• Assured follow-up examinations;
• Healthy eyes besides clinically significant bilateral age-related cataract.
• Distance corrected visual acuity ≤ 0.3 logMAR Normal findings in the medical history and physical examination
• Calculated IOL power within the available dioptre range;
• Biometry measurement/cataract density compatible with the IOLMaster evaluation.

Per operative inclusion criteria:

• IOL implanted in the capsular bag;
• The 2 IOL models (CT LUCIA 611P and CT ASPHINA 409MP) have been implanted in the 2 eyes of one patient;
• No intraoperative complications; no damaged capsular bag, no intraocular haemorrhage; no can opener rhexis.

Exclusion criteria

• Allergy to heparin
• Monophthalmic patient
• Ocular disorders, other than cataract, that could potentially cause future acuity loss to a level of 0.20 logMAR (best-corrected) or worse in either eye;
• Any anterior segment pathology that could significantly affect outcomes (e.g. chronic uveitis, iritis, corneal dystrophy, etc.);
• Floppy iris syndrome;
• Diabetic retinopathy;
• Traumatic cataract;
• Aniridia;
• Microphthalmus;
• Amblyopia;
• Degenerative visual disorders (e.g. macular degeneration, optic nerve atrophy, or retinal disorders);
• Patient expected to require retinal laser treatment before the end of the last follow-up;
• Previous intraocular and corneal surgery;
• Expected postop. astigmatism greater than 1 D;
• Any type of corneal disorder;
• Dementia;
• Pseudoexfoliation syndrome (PEX);
• Glaucoma or IOP higher than 24mmHg under ocular hypertension treatment;
• Any other pathology or condition presenting, according to the investigator opinion, a risk for the patient.
• Pregnancy and/or lactation